SNCA: Major genetic modifier of age at onset of Parkinson's disease
ABSTRACT Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis i...
Gespeichert in:
Veröffentlicht in: | Movement disorders 2013-08, Vol.28 (9), p.1217-1221 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1221 |
---|---|
container_issue | 9 |
container_start_page | 1217 |
container_title | Movement disorders |
container_volume | 28 |
creator | Brockmann, Kathrin Schulte, Claudia Hauser, Ann-Kathrin Lichtner, Peter Huber, Heiko Maetzler, Walter Berg, Daniela Gasser, Thomas |
description | ABSTRACT
Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society |
doi_str_mv | 10.1002/mds.25469 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1430396074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3061320421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</originalsourceid><addsrcrecordid>eNp1kE1LwzAYgIMoOqcH_4AUPKiHar7beBvTTcVN8QOPIW3fSubazKRD9-_tnHoQvCQEnvch74PQHsEnBGN6WhXhhAou1RrqEMFInFKRrKMOTlMRM5KKLbQdwgRjQgSRm2iLMplwlsoO6j-M-72zaGQmzkcvUENj86hyhS0t-MiVkXmByDSRqwM0y_ed8a-2Dq4-DFFhA5gAO2ijNNMAu993Fz0NLh77l_HN7fCq37uJc6aIik0pBJUKJ0BJCoopoIwzoJgWpD0FyAIXlEBJuIEsS4qMc1HKJDO05FmOWRcdrbwz797mEBpd2ZDDdGpqcPOgCWeYKYnb1bro4A86cXNft79rKaoEJoouhccrKvcuBA-lnnlbGb_QBOtlWd2W1V9lW3b_2zjPKih-yZ-ULXC6At7tFBb_m_To_OFHGa8mbGjg43eiDaxlwhKhn8dDfc-FZNfXQg_YJw-mjnE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1429501920</pqid></control><display><type>article</type><title>SNCA: Major genetic modifier of age at onset of Parkinson's disease</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Brockmann, Kathrin ; Schulte, Claudia ; Hauser, Ann-Kathrin ; Lichtner, Peter ; Huber, Heiko ; Maetzler, Walter ; Berg, Daniela ; Gasser, Thomas</creator><creatorcontrib>Brockmann, Kathrin ; Schulte, Claudia ; Hauser, Ann-Kathrin ; Lichtner, Peter ; Huber, Heiko ; Maetzler, Walter ; Berg, Daniela ; Gasser, Thomas</creatorcontrib><description>ABSTRACT
Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.25469</identifier><identifier>PMID: 23674386</identifier><identifier>CODEN: MOVDEA</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adult ; age at onset ; Age of Onset ; Aged ; alpha-Synuclein - genetics ; Cohort Studies ; Female ; Genetic Association Studies ; genetics ; Humans ; Linear Models ; Male ; Middle Aged ; Movement disorders ; Mutation - genetics ; Parkinson Disease - genetics ; Parkinson Disease - physiopathology ; Parkinson's disease ; Polymorphism, Single Nucleotide - genetics ; SNCA</subject><ispartof>Movement disorders, 2013-08, Vol.28 (9), p.1217-1221</ispartof><rights>Copyright © 2013 Movement Disorder Society</rights><rights>Copyright © 2013 Movement Disorder Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</citedby><cites>FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.25469$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.25469$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23674386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brockmann, Kathrin</creatorcontrib><creatorcontrib>Schulte, Claudia</creatorcontrib><creatorcontrib>Hauser, Ann-Kathrin</creatorcontrib><creatorcontrib>Lichtner, Peter</creatorcontrib><creatorcontrib>Huber, Heiko</creatorcontrib><creatorcontrib>Maetzler, Walter</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Gasser, Thomas</creatorcontrib><title>SNCA: Major genetic modifier of age at onset of Parkinson's disease</title><title>Movement disorders</title><addtitle>Mov Disord</addtitle><description>ABSTRACT
Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society</description><subject>Adult</subject><subject>age at onset</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>alpha-Synuclein - genetics</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Genetic Association Studies</subject><subject>genetics</subject><subject>Humans</subject><subject>Linear Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Movement disorders</subject><subject>Mutation - genetics</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson's disease</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>SNCA</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LwzAYgIMoOqcH_4AUPKiHar7beBvTTcVN8QOPIW3fSubazKRD9-_tnHoQvCQEnvch74PQHsEnBGN6WhXhhAou1RrqEMFInFKRrKMOTlMRM5KKLbQdwgRjQgSRm2iLMplwlsoO6j-M-72zaGQmzkcvUENj86hyhS0t-MiVkXmByDSRqwM0y_ed8a-2Dq4-DFFhA5gAO2ijNNMAu993Fz0NLh77l_HN7fCq37uJc6aIik0pBJUKJ0BJCoopoIwzoJgWpD0FyAIXlEBJuIEsS4qMc1HKJDO05FmOWRcdrbwz797mEBpd2ZDDdGpqcPOgCWeYKYnb1bro4A86cXNft79rKaoEJoouhccrKvcuBA-lnnlbGb_QBOtlWd2W1V9lW3b_2zjPKih-yZ-ULXC6At7tFBb_m_To_OFHGa8mbGjg43eiDaxlwhKhn8dDfc-FZNfXQg_YJw-mjnE</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Brockmann, Kathrin</creator><creator>Schulte, Claudia</creator><creator>Hauser, Ann-Kathrin</creator><creator>Lichtner, Peter</creator><creator>Huber, Heiko</creator><creator>Maetzler, Walter</creator><creator>Berg, Daniela</creator><creator>Gasser, Thomas</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>SNCA: Major genetic modifier of age at onset of Parkinson's disease</title><author>Brockmann, Kathrin ; Schulte, Claudia ; Hauser, Ann-Kathrin ; Lichtner, Peter ; Huber, Heiko ; Maetzler, Walter ; Berg, Daniela ; Gasser, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>age at onset</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>alpha-Synuclein - genetics</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Genetic Association Studies</topic><topic>genetics</topic><topic>Humans</topic><topic>Linear Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Movement disorders</topic><topic>Mutation - genetics</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson's disease</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>SNCA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brockmann, Kathrin</creatorcontrib><creatorcontrib>Schulte, Claudia</creatorcontrib><creatorcontrib>Hauser, Ann-Kathrin</creatorcontrib><creatorcontrib>Lichtner, Peter</creatorcontrib><creatorcontrib>Huber, Heiko</creatorcontrib><creatorcontrib>Maetzler, Walter</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Gasser, Thomas</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brockmann, Kathrin</au><au>Schulte, Claudia</au><au>Hauser, Ann-Kathrin</au><au>Lichtner, Peter</au><au>Huber, Heiko</au><au>Maetzler, Walter</au><au>Berg, Daniela</au><au>Gasser, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SNCA: Major genetic modifier of age at onset of Parkinson's disease</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov Disord</addtitle><date>2013-08</date><risdate>2013</risdate><volume>28</volume><issue>9</issue><spage>1217</spage><epage>1221</epage><pages>1217-1221</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><coden>MOVDEA</coden><abstract>ABSTRACT
Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23674386</pmid><doi>10.1002/mds.25469</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3185 |
ispartof | Movement disorders, 2013-08, Vol.28 (9), p.1217-1221 |
issn | 0885-3185 1531-8257 |
language | eng |
recordid | cdi_proquest_miscellaneous_1430396074 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adult age at onset Age of Onset Aged alpha-Synuclein - genetics Cohort Studies Female Genetic Association Studies genetics Humans Linear Models Male Middle Aged Movement disorders Mutation - genetics Parkinson Disease - genetics Parkinson Disease - physiopathology Parkinson's disease Polymorphism, Single Nucleotide - genetics SNCA |
title | SNCA: Major genetic modifier of age at onset of Parkinson's disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A39%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SNCA:%20Major%20genetic%20modifier%20of%20age%20at%20onset%20of%20Parkinson's%20disease&rft.jtitle=Movement%20disorders&rft.au=Brockmann,%20Kathrin&rft.date=2013-08&rft.volume=28&rft.issue=9&rft.spage=1217&rft.epage=1221&rft.pages=1217-1221&rft.issn=0885-3185&rft.eissn=1531-8257&rft.coden=MOVDEA&rft_id=info:doi/10.1002/mds.25469&rft_dat=%3Cproquest_cross%3E3061320421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1429501920&rft_id=info:pmid/23674386&rfr_iscdi=true |